ZARXIO 300 ug/.5mL
filgrastim-sndz · INJECTION, SOLUTION · Sandoz Inc.
No Recall History
Plain English
ZARXIO is a injection, solution containing filgrastim-sndz at 300 ug/.5mL, taken intravenous. Manufactured by Sandoz Inc..
Key Facts
- Brand Name
- ZARXIO
- Generic Name
- filgrastim-sndz
- NDC Code (Product)
61314-318- Manufacturer
- Sandoz Inc.
- Strength
- 300 ug/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125553
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 03/06/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is ZARXIO used for?
ZARXIO contains filgrastim-sndz. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is ZARXIO a controlled substance?
ZARXIO is not classified as a controlled substance by the DEA.
What is the generic name for ZARXIO?
The generic name for ZARXIO is filgrastim-sndz. There are no other listed brand versions of filgrastim-sndz.
What is the NDC code for ZARXIO 300 ug/.5mL?
The NDC (National Drug Code) for ZARXIO 300 ug/.5mL is 61314-318, listed by Sandoz Inc..
Other ZARXIO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)